Cargando…

Regorafenib: Adding to the Armamentarium for Refractory Colorectal Cancer and GIST

Detalles Bibliográficos
Autores principales:	Roman, Danielle, Whiteside, Rachelle
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Harborside Press 2013
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4093419/ https://www.ncbi.nlm.nih.gov/pubmed/25031991

Ejemplares similares

Regorafenib as Salvage Treatment in Korean Patients with Refractory Metastatic Colorectal Cancer
por: Kim, Seung Tae, et al.
Publicado: (2015)

Filling the Gap: The Immune Therapeutic Armamentarium for Relapsed/Refractory Hodgkin Lymphoma
por: Hazane Leroyer, Esther, et al.
Publicado: (2022)

The use of regorafenib for patients with refractory metastatic colorectal cancer in clinical practice
por: Yoon, Sang Eun, et al.
Publicado: (2018)

A meta-analysis of safety and efficacy of regorafenib for refractory metastatic colorectal cancer
por: Xue, Wu-Song, et al.
Publicado: (2018)

Expanding the armamentarium for the spondyloarthropathies
por: Peloso, Paul M, et al.
Publicado: (2004)

Towards shedding some light on regorafenib treatment in refractory metastatic colorectal cancer
por: Prager, Gerald, et al.
Publicado: (2017)

The Impact of Primary Tumor Sidedness on the Effect of Regorafenib in Refractory Metastatic Colorectal Cancer
por: Yoon, Sang Eun, et al.
Publicado: (2019)

Regorafenib in Refractory Metastatic Colorectal Cancer: A Multi-Center Retrospective Study
por: Xu, Donghao, et al.
Publicado: (2022)

The American Armamentarium Chirurgicum
Publicado: (1889)

Toxicity management of regorafenib in patients with gastro-intestinal stromal tumour (GIST) in a tertiary cancer centre
por: Chamberlain, Florence, et al.
Publicado: (2020)

The Modern Surgical Armamentarium
Publicado: (1873)

Regorafenib assessment in refractory advanced colorectal cancer: RegARd-C study protocol
por: Hendlisz, Alain, et al.
Publicado: (2015)

Armamentarium and Sterilization
por: ELEAZER, PAUL D.
Publicado: (2011)

Critical appraisal of the use of regorafenib in the management of colorectal cancer
por: Festino, Lucia, et al.
Publicado: (2013)

Molecular profiling in the treatment of colorectal cancer: focus on regorafenib
por: Yan, Yiyi, et al.
Publicado: (2015)

Practical considerations in the use of regorafenib in metastatic colorectal cancer
por: Loupakis, Fotios, et al.
Publicado: (2020)

Should flexible ureteroscope be added to our armamentarium to treat stone disease?
por: Dharaskar, Anand, et al.
Publicado: (2008)

Gracilis Myocutaneous Flap: Adding to the Armamentarium of Complex Sacrococcygeal Defect Reconstruction
por: Preetha Rani, K., et al.
Publicado: (2019)

Management of a refractory leak after sleeve gastrectomy: the endoscopic armamentarium
por: Yu, Jessica X., et al.
Publicado: (2019)

A meta-analysis comparing regorafenib with TAS-102 for treating refractory metastatic colorectal cancer
por: Su, Guan-Li, et al.
Publicado: (2020)

American Armamentarium Chirurgicum; Tieman
Publicado: (1889)

Acromegaly: Role of Surgery in the Therapeutic Armamentarium
por: Guinto, Gerardo, et al.
Publicado: (2012)

Utilizing Artificial Intelligence in Critical Care: Adding A Handy Tool to Our Armamentarium
por: Sharma, Munish, et al.
Publicado: (2021)

A polymorphism in the cachexia-associated gene INHBA predicts efficacy of regorafenib in patients with refractory metastatic colorectal cancer
por: Miyamoto, Yuji, et al.
Publicado: (2020)

Meeting An Unmet Need in Metastatic Colorectal Carcinoma with Regorafenib
por: Melosky, Barbara
Publicado: (2016)

Enzalutamide: A New Agent for the Prostate Cancer Treatment Armamentarium
por: McCutcheon, Stephanie B.
Publicado: (2013)

Immunotherapy: Newer Therapeutic Armamentarium against Cancer Stem Cells
por: Singh, Saurabh Pratap, et al.
Publicado: (2020)

Tumour pharmacodynamics and circulating cell free DNA in patients with refractory colorectal carcinoma treated with regorafenib
por: Wong, Andrea Li Ann, et al.
Publicado: (2015)

Immune Checkpoint Modulators: An Emerging Antiglioma Armamentarium
por: Kim, Eileen S., et al.
Publicado: (2016)

Cinnamon in Anticancer Armamentarium: A Molecular Approach
por: Dutta, Anindita, et al.
Publicado: (2018)

Regorafenib and Nivolumab or Pembrolizumab Combination and Circulating Tumor DNA Response Assessment in Refractory Microsatellite Stable Colorectal Cancer
por: Wang, Chongkai, et al.
Publicado: (2020)

Case report: Efficacy and safety of regorafenib plus fluorouracil combination therapy in the treatment of refractory metastatic colorectal cancer
por: Haque, Emaan, et al.
Publicado: (2022)

Prolonged Response to Regorafenib in a Patient with Iodine Refractory Thyroid Cancer
por: Wong, Selina K., et al.
Publicado: (2019)

The obstetrician's armamentarium: historical obstetric instruments and their inventors
por: Lawrence, Ghislaine M
Publicado: (2003)

Mixed response on regorafenib treatment for GIST (gastro-intestinal stromal tumor) according to (18)F–FDG-PET/CT
por: Van Weehaeghe, Donatienne, et al.
Publicado: (2018)

Practice patterns and outcomes with the use of regorafenib in metastatic colorectal cancer: Results from the Regorafenib in Metastatic colorectal cancer - An Indian exploratory analysis study
por: Ramaswamy, Anant, et al.
Publicado: (2019)

Allografts: expanding the surgeon’s armamentarium
por: Ahmed, Norus, et al.
Publicado: (2022)

SHP-1 is a target of regorafenib in colorectal cancer
por: Fan, Li-Ching, et al.
Publicado: (2014)

Factors Associated With Regorafenib Adherence With Metastatic Colorectal Cancer
por: Kawakami, Kazuyoshi, et al.
Publicado: (2019)

Synergistic antitumor activity of regorafenib and rosuvastatin in colorectal cancer
por: Yuan, Tao, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_vih1l5s4slbo8qg2slt4f1cek5